- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05876260
Effect of Post-exercise Nutrition on Glycemia in Women (PEN)
Influence of Post-exercise Greek Yogurt on 24 h Glycemic Control in Women With Overweight/Obesity
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Following the acquisition of informed consent, eligibility to participate in the study will be determined using questionnaires. Participants will undergo baseline testing at our laboratory at the University of Toronto to determine cardiorespiratory fitness, body composition and undergo exercise familiarization.
Eligible participants will be assigned, in a random order, to two metabolic trials approximately 4 weeks apart that involve 4 days of controlled diet and exercise. Each trial takes place over 4 days, but participants are not required to come to the laboratory on all days. The two trials involve: 1) Exercise + Greek Yogurt (GY) 2) Exercise + a carbohydrate-based study supplement (SS).
During the 4 day trials, participants consume controlled diets and the study supplements (GY and SS). On 1 of these days participants will perform exercise in our lab followed by the consumption of GY or SS. Various outcomes will be measured throughout the trial, including glycemic control (via continuous glucose monitoring), fat oxidation, appetite and health outcomes in blood samples.
Throughout the duration of the study, participants will be asked to maintain their habitual diet and physical activity patterns, and maintain their current body weight.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jenna Gillen, PhD
- Phone Number: 14169783244
- Email: jenna.gillen@utoronto.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M4K 1V2
- Recruiting
- Jenna Gillen
-
Contact:
- Jenna Gillen
- Email: jenna.gillen@utoronto.ca
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-45 yrs
- BMI ≥27 kg/m2
- Elevated waist circumference (≥88 cm)
- ≤2 structured exercise sessions/week
- Weight stable (within ± 2kg for at least 6 months)
- Experiencing regular natural menstrual cycles
- Non-smoker
Exclusion Criteria:
- Allergy to dairy foods
- Diagnosed lactose intolerance or an aversion to foods provided during the study (e.g., post-exercise snacks)
- Previous history of cardiovascular or metabolic disease
- The use of medication for managing blood glucose or lipid metabolism
- Current use of oral contraceptives or use within the last 3 months
- Irregular menstrual cycles (<21 days or >35 days)
- Pregnant or lactating
- Recreational tobacco or cannabis use
- Inability to perform the study exercise protocols
- Actively engaging in a low-carbohydrate diet (e.g., ketogenic, Atkins).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-intensity interval exercise and post-exercise Greek yogurt (HIIE+GY)
Participants will consume greek yogurt following a single session of exercise
|
Following 2 days of controlled diet, participants will consume greek yogurt following high-intensity interval exercise
Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast
|
Active Comparator: High-intensity interval exercise and post-exercise carbohydrate study supplement (HIIE +SS)
Participants will consume a carbohydrate-based study supplement following a single session of exercise
|
Following 2 days of controlled diet, participants will perform high-intensity interval exercise following an overnight fast
Following 2 days of controlled diet, participants will consume a carbohydrate-based study supplement following high-intensity interval exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postprandial glycemia
Time Frame: 24 hour post-exercise
|
Postprandial glucose exposure assessed using continuous glucose monitoring
|
24 hour post-exercise
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24 hours average glucose
Time Frame: 24 hours post-exercise
|
Average glucose concentration over 24 hours
|
24 hours post-exercise
|
Nocturnal glucose
Time Frame: 6-8 hours
|
Overnight glucose concentration
|
6-8 hours
|
Nocturnal glucose
Time Frame: 6-8 hours
|
Overnight glucose exposure (area under the curve)
|
6-8 hours
|
Glycemic variability
Time Frame: 24 hours
|
Continuous overall net glycemic action (CONGA)
|
24 hours
|
Glycemic variability
Time Frame: 24 hours
|
Standard deviation (SD)
|
24 hours
|
Glycemic variability
Time Frame: 24 hours
|
Coefficient of variation (%CV)
|
24 hours
|
Post-exercise fat oxidation
Time Frame: 1, 2 and 3 hours post-exercise
|
Fat oxidation assessed with indirect calorimetry
|
1, 2 and 3 hours post-exercise
|
Fasting glucose concentration
Time Frame: 24 hours post-exercise
|
Venous blood sampling
|
24 hours post-exercise
|
Fasting insulin concentration
Time Frame: 24 hours post-exercise
|
Venous blood sampling
|
24 hours post-exercise
|
Fasting insulin resistance
Time Frame: 24 hours post-exercise
|
Homeostasis Model Assessment (HOMA2)
|
24 hours post-exercise
|
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
|
Serum concentration of CTX
|
30, 90, and 180 minutes and 24 hours post-exercise
|
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
|
Serum concentration of OPG
|
30, 90, and 180 minutes and 24 hours post-exercise
|
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
|
Serum concentration of RANKL
|
30, 90, and 180 minutes and 24 hours post-exercise
|
Bone metabolism
Time Frame: 30, 90, and 180 minutes and 24 hours post-exercise
|
Serum concentration of OC
|
30, 90, and 180 minutes and 24 hours post-exercise
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jenna Gillen, PhD, University of Toronto
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 42756-3
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
University Hospital, LilleNational Research Agency, France; European Union; University of Lille Nord de... and other collaboratorsNot yet recruitingOverweight and Obesity | Overweight, Childhood | Overweight, Infant
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Memorial Sloan Kettering Cancer CenterRecruitingObesity | Overweight | Overweight and Obesity | Obese | Overweight or ObesityUnited States
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
-
University of British ColumbiaTerminatedOverweight and ObesityCanada
-
National Taiwan University HospitalCompleted
Clinical Trials on Greek yogurt
-
Brock UniversityCompletedInflammatory Response | Sports PerformanceCanada
-
Mount Saint Vincent UniversityUniversity of TorontoCompletedEating | Food | AppetiteCanada
-
University of TorontoCompletedObesity | Type 2 Diabetes MellitusCanada
-
Al-Balqa Applied UniversityUniversity of JordanCompletedBody Weight | Appetitive Behavior | Hormone Deficiency | Dietary ExposureJordan
-
Brock UniversityYork UniversityRecruitingInflammation | Bone Growth AbnormalCanada
-
York UniversityRecruitingInflammation | Healthy | BoneCanada
-
Democritus University of ThraceCompletedPresbyopia | Patient Satisfaction | PersonalityGreece
-
Jose María Maya MejíaUnknown
-
Instituto de Investigación Hospital Universitario...Go Fruselva, S.L.Completed